243 related articles for article (PubMed ID: 9467185)
1. Evaluation of intrinsic sympathomimetic activity of bucindolol and carvedilol in rat heart.
Willette RN; Mitchell MP; Ohlstein EH; Lukas MA; Ruffolo RR
Pharmacology; 1998 Jan; 56(1):30-6. PubMed ID: 9467185
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo characterization of intrinsic sympathomimetic activity in normal and heart failure rats.
Willette RN; Aiyar N; Yue TL; Mitchell MP; Disa J; Storer BL; Naselsky DP; Stadel JM; Ohlstein EH; Ruffolo RR
J Pharmacol Exp Ther; 1999 Apr; 289(1):48-53. PubMed ID: 10086986
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
4. Different intrinsic activities of bucindolol, carvedilol and metoprolol in human failing myocardium.
Maack C; Cremers B; Flesch M; Höper A; Südkamp M; Böhm M
Br J Pharmacol; 2000 Jul; 130(5):1131-9. PubMed ID: 10882399
[TBL] [Abstract][Full Text] [Related]
5. The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors.
Nichols AJ; Sulpizio AC; Ashton DJ; Hieble JP; Ruffolo RR
Chirality; 1989; 1(4):265-70. PubMed ID: 2577144
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of bucindolol and carvedilol on noradenaline-induced hypertrophic response in ventricular cardiomyocytes of adult rats.
Pönicke K; Heinroth-Hoffmann I; Brodde OE
J Pharmacol Exp Ther; 2002 Apr; 301(1):71-6. PubMed ID: 11907159
[TBL] [Abstract][Full Text] [Related]
7. Bucindolol exerts agonistic activity on the propranolol-insensitive state of beta1-adrenoceptors in human myocardium.
Bundkirchen A; Brixius K; Bölck B; Schwinger RH
J Pharmacol Exp Ther; 2002 Mar; 300(3):794-801. PubMed ID: 11861783
[TBL] [Abstract][Full Text] [Related]
8. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol.
Nichols AJ; Gellai M; Ruffolo RR
Fundam Clin Pharmacol; 1991; 5(1):25-38. PubMed ID: 1712335
[TBL] [Abstract][Full Text] [Related]
9. Bucindolol displays intrinsic sympathomimetic activity in human myocardium.
Andreka P; Aiyar N; Olson LC; Wei JQ; Turner MS; Webster KA; Ohlstein EH; Bishopric NH
Circulation; 2002 May; 105(20):2429-34. PubMed ID: 12021232
[TBL] [Abstract][Full Text] [Related]
10. Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.
Dunn CJ; Lea AP; Wagstaff AJ
Drugs; 1997 Jul; 54(1):161-85. PubMed ID: 9211087
[TBL] [Abstract][Full Text] [Related]
11. Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium.
Brixius K; Bundkirchen A; Bölck B; Mehlhorn U; Schwinger RH
Br J Pharmacol; 2001 Aug; 133(8):1330-8. PubMed ID: 11498519
[TBL] [Abstract][Full Text] [Related]
12. Beta-adrenergic blockade in the treatment of congestive heart failure.
Denbow CE
West Indian Med J; 2000 Jun; 49(2):102-7. PubMed ID: 10948844
[TBL] [Abstract][Full Text] [Related]
13. Studies on the vasodilator actions of bucindolol in the rat.
Marwood JF; Stokes GS
Clin Exp Pharmacol Physiol; 1986 Jan; 13(1):59-68. PubMed ID: 3708914
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
Bril A; Slivjak M; DiMartino MJ; Feuerstein GZ; Linee P; Poyser RH; Ruffolo RR; Smith EF
Cardiovasc Res; 1992 May; 26(5):518-25. PubMed ID: 1359930
[TBL] [Abstract][Full Text] [Related]
15. [Hormonal hyperactivity in heart failure. Differences in beta blockers].
Beuckelmann DJ
Herz; 2002 Aug; 27 Suppl 1():9-15. PubMed ID: 12229258
[TBL] [Abstract][Full Text] [Related]
16. [Effect of carvedilol on survival in severe chronic heart failure. A trial of the beta-blocker bucindolol in patient with advanced heart failure].
Bosimini E
Ital Heart J Suppl; 2001 Aug; 2(8):919-21. PubMed ID: 11582729
[No Abstract] [Full Text] [Related]
17. Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol.
Lindenfeld J; Lowes BD; Bristow MR
Ann Pharmacother; 1999 Dec; 33(12):1266-9. PubMed ID: 10630826
[TBL] [Abstract][Full Text] [Related]
18. Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents.
Coats AJ
Drugs Aging; 2006; 23(2):93-9. PubMed ID: 16536633
[TBL] [Abstract][Full Text] [Related]
19. Selectivity of the intrinsic sympathomimetic activity of the beta-adrenergic blocking drug bucindolol.
Leff AR; Garrity ER; Munoz NM; Tallet J; Cavigelli M; Deitchman D; Rajfer SI
J Cardiovasc Pharmacol; 1984; 6(5):859-66. PubMed ID: 6209492
[TBL] [Abstract][Full Text] [Related]
20. Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor.
Maack C; Böhm M; Vlaskin L; Dabew E; Lorenz K; Schäfers HJ; Lohse MJ; Engelhardt S
Circulation; 2003 Jul; 108(3):348-53. PubMed ID: 12847069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
